Skip to main content

Table 3 Results of repeated measures ANOVA

From: Increased sleep duration precedes the improvement of other symptom domains during the treatment of acute mania: a retrospective chart review

a. Within subjects univariate tests

Measure

Type III Sum of Squares

df

Mean Square

F

Sig.

Sleep

84.88

6

14.15

5.55

<.001

Mania

4042.82

6

673.80

54.14

<.001

Psychosis

1117.91

6

186.32

44.68

<.001

b. Within subjects contrasts

Measure

Type III Sum of Squares

df

Mean Square

F

Sig.

Sleep Linear

70.58

1

70.578

17.83

<.001

Sleep Quadratic

4.43

1

4.429

1.55

.22

Sleep Cubic

8.81

1

8.813

4.04

.05

Mania Linear

3960.19

1

3960.187

134.66

<.001

Mania Quadratic

58.65

1

58.647

4.61

.03

Mania Cubic

19.73

1

19.734

2.01

.16

Psychosis Linear

1117.49

1

1117.487

108.57

<.001

Psychosis Quadratic

.06

1

.056

.01

.92

Psychosis Cubic

.03

1

.028

.01

.92

c. Multivariate tests of between subjects effects

Measure

Pillaiā€™s Trace

df

Mean Square

F

Sig.

BZD cumulative dose

.14

78

3.00

4.36

.01

DPH cumulative dose

.06

78

3.00

1.61

.19

FGA cumulative dose

.05

78

3.00

1.33

.27

SGA cumulative dose

.05

78

3.00

1.21

.31

d. Multivariate tests of within subjects effects

Measure

Pillaiā€™s Trace

df

Mean Square

F

Sig.

Time

.56

63

18.00

4.40

<.001

BZD dose * Time

.32

63

18.00

1.62

.08

DPH dose * Time

.26

63

18.00

1.24

.26

FGA dose * Time

.19

63

18.00

.82

.67

SGA dose * Time

.21

63

18.00

.94

.54